Sanofi Files 6-K Report for July 2025
Ticker: SNYNF · Form: 6-K · Filed: Jul 31, 2025 · CIK: 1121404
| Field | Detail |
|---|---|
| Company | Sanofi (SNYNF) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, press-release
TL;DR
Sanofi dropped a July 2025 update (6-K filing) – check Exhibit 99.1 for deets.
AI Summary
On July 31, 2025, Sanofi filed a Form 6-K, reporting on events for the month of July 2025. The filing incorporates by reference a press release issued by the company as Exhibit 99.1. Sanofi is a pharmaceutical preparations company based in Paris, France.
Why It Matters
This filing provides an update on Sanofi's activities and disclosures for July 2025, which could contain important information for investors regarding the company's operations and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing (Form 6-K) that primarily incorporates a press release, indicating no immediate or significant new risks are being disclosed.
Key Players & Entities
- Sanofi (company) — Filer of the report
- 001-31368 (company) — SEC file number for Sanofi
- 46, avenue de la Grande Armée, 75017 Paris, FRANCE (company) — Principal executive offices address
- July 2025 (date) — Reporting period for the 6-K
- Exhibit 99.1 (document) — Press release incorporated by reference
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information for the month of July 2025, specifically incorporating by reference a press release issued by Sanofi as Exhibit 99.1.
What is Sanofi's SEC file number?
Sanofi's SEC file number is 001-31368.
Where are Sanofi's principal executive offices located?
Sanofi's principal executive offices are located at 46, avenue de la Grande Armée, 75017 Paris, FRANCE.
What period does this report cover?
This report covers the month of July 2025.
What is attached as Exhibit 99.1?
A press release issued by Sanofi in July 2025 is attached as Exhibit 99.1.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 31, 2025 regarding Sanofi (SNYNF).